REVOVIR Trademark

Trademark Overview


On Tuesday, November 1, 2005, a trademark application was filed for REVOVIR with the United States Patent and Trademark Office. The USPTO has given the REVOVIR trademark a serial number of 79023125. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Sunday, November 1, 2015. This trademark is owned by BUKWANG PHARM CO., LTD.. The REVOVIR trademark is filed in the Pharmaceutical Products category with the following description:

Antivirals; pharmaceutical preparations for treating hepatitis; therapeutic preparations for treating hepatic disease, namely, antiviral nucleosides and Alanine Aminotransferase or Alanine Transaminase normalizations; preparations for normalizing or restoring metabolism; agents for immunity adjustment, namely, oral, transdermal, or injectable antiviral agents; biological preparations for medical purposes; agents affecting digestive organs, namely, agents for restoration of hepatic function; agents affecting the central nervous system, namely, agents for inhibiting virus reproduction; antibiotic preparations; and chemotherapy medicines, namely, pharmaceutical preparations for use in chemotherapy
revovir

General Information


Serial Number79023125
Word MarkREVOVIR
Filing DateTuesday, November 1, 2005
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateSunday, November 1, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 6, 2007

Trademark Statements


Goods and ServicesAntivirals; pharmaceutical preparations for treating hepatitis; therapeutic preparations for treating hepatic disease, namely, antiviral nucleosides and Alanine Aminotransferase or Alanine Transaminase normalizations; preparations for normalizing or restoring metabolism; agents for immunity adjustment, namely, oral, transdermal, or injectable antiviral agents; biological preparations for medical purposes; agents affecting digestive organs, namely, agents for restoration of hepatic function; agents affecting the central nervous system, namely, agents for inhibiting virus reproduction; antibiotic preparations; and chemotherapy medicines, namely, pharmaceutical preparations for use in chemotherapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, August 21, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBUKWANG PHARM CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressKR

Party NameBUKWANG PHARM CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressKR

Trademark Events


Event DateEvent Description
Friday, June 17, 2016UNDELIVERABLE MAIL - NO ACTION TAKEN
Friday, June 3, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, June 2, 2016DEATH OF INTERNATIONAL REGISTRATION
Friday, September 12, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, August 21, 2008FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 21, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 21, 2007ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Tuesday, August 21, 2007ABANDONMENT - AFTER INTER PARTES DECISION
Tuesday, August 21, 2007OPPOSITION SUSTAINED NO. 999999
Thursday, July 26, 2007LIMITATION OF GOODS RECEIVED FROM IB
Friday, June 15, 2007REFUSAL PROCESSED BY IB
Friday, May 25, 2007OPPOSITION INSTITUTED NO. 999999
Thursday, May 24, 2007OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Thursday, May 24, 2007OPPOSITION NOTICE (IB REFUSAL) CREATED
Monday, February 26, 2007EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 6, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 17, 2007NOTICE OF PUBLICATION
Monday, December 11, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 11, 2006ASSIGNED TO LIE
Wednesday, November 22, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 18, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 17, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 17, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 29, 2006REFUSAL PROCESSED BY IB
Tuesday, June 6, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 6, 2006REFUSAL PROCESSED BY MPU
Sunday, June 4, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, June 3, 2006NON-FINAL ACTION WRITTEN
Friday, June 2, 2006ASSIGNED TO EXAMINER
Friday, June 2, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, June 1, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB